ViiV Healthcare
2009
FOUNDED
PRIVATE
STATUS
601-700
EMPLOYEES
2ndary - Private
LATEST DEAL TYPE
2
FINANCING ROUNDS
1
INVESTMENTS
Description
Operator of a global specialist HIV company intended to deliver innovative new options for the care and treatment of people living with HIV/AIDS. The company's products include dolutegravir, zidovudine, fosamprenavi, maraviroc, abacavir, and nelfinavir and delavirdine mesylate and provides nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitor, protease inhibitors, and CCR5 antagonist for the treatment of AIDS.
Website
Formerly Known As
GlaxoSmithKline Newco Limited
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors/Wholesale
Other Industries
Drug Discovery
Other Healthcare
Biotechnology
Primary Office
- 980 Great West Road
- Brentford TW8 9GS
- England, United Kingdom
+44 020 0000 0000
ViiV Healthcare Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore ViiV Healthcare‘s full profile, request access.
Request full access to PitchBookViiV Healthcare Competitors (43)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CymaBay Therapeutics | Formerly PE-Backed | Newark, CA | 00 | 00000 | 00000000 | 00000 |
| 0000000000 | Venture Capital-Backed | Abingdon, United Kingdom | 000 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Redwood City, CA | 00 | 00000 | 000000&0 | 00000 |
| 000000 | Formerly VC-backed | Lyon, France | 000 | 000.00 | 00000000 | 000.00 |
| 00000000 000000000 | Corporation | West Conshohocken, PA | 00 | 000.00 | 000000 - 000 | 000.00 |
ViiV Healthcare Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000-00000 0000 | 22-Feb-2016 | 000000000 00000 00 | 000 | Drug Discovery | 000000000 00000 |
ViiV Healthcare Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore ViiV Healthcare‘s full profile, request access.
Request full access to PitchBookViiV Healthcare Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Deborah Waterhouse | Chief Executive Officer | ||
| Andries Jerome | Chief Financial Officer | ||
| John Pottage Jr. | Senior Vice President and Chief Scientific and Medical Officer |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »